Hepatitis B virus genotypes and resistance mutations in patients under long term lamivudine therapy: Characterization of genotype G in Brazil

BMC Microbiology

Volumn 8, Issue , 2008, Pages

  Bottecchia, Marcelle ^a   Souto, Francisco J D ^b   Ó, Kycia M R ^a,c   Amendola, Marcia ^d   Brandão, Carlos E ^d   Niel, Christian ^a   Gomes, Selma A ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b UNIVERSIDADE FEDERAL DE MATO GROSSO   (Brazil)

^c Hospital Alcides Carneiro   (Brazil)

^d HOSPITAL UNIVERSITÁRIO GAFFRÉE E GUINLE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

LAMIVUDINE; VIRUS DNA; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADULT; AGED; ARTICLE; BRAZIL; CLINICAL ARTICLE; FEMALE; GENE IDENTIFICATION; GENE SEQUENCE; GENETIC VARIABILITY; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HOMOSEXUALITY; HUMAN; MALE; MUTANT; MUTATION; NUCLEOTIDE SEQUENCE; SAMPLE; SOUTH AMERICA; VIRUS GENOME; VIRUS ISOLATION; VIRUS LOAD; VIRUS RESISTANCE; VIRUS TRANSMISSION; ANTIVIRAL RESISTANCE; CHILD; CLASSIFICATION; CLINICAL TRIAL; DRUG EFFECT; GENETIC POLYMORPHISM; GENETICS; HOSPITAL; MIDDLE AGED; MOLECULAR GENETICS; MULTICENTER STUDY; PHYLOGENY; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; VIROLOGY;

HEPATITIS B VIRUS;

ADULT; AGED; BRAZIL; CHILD; DRUG RESISTANCE, VIRAL; FEMALE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HOSPITALS; HUMANS; LAMIVUDINE; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; PHYLOGENY; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; REVERSE TRANSCRIPTASE INHIBITORS;

EID: 39149121860     PISSN: 14712180     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/1471-2180-8-11     Document Type: Article

References (43)

1. Hepatitis B virus infection: epidemiology and vaccination. CW Shepard EP Simard L Finelli AE Fiore BP Bell, Epidemiol Rev 2006 28 112 125 10.1093/epirev/mxj009 16754644
2. Genotype H: a new Amerindian genotype of hepatitis B virus revealed in Central America. P Arauz-Ruiz H Norder BH Robertson LO Magnius, J Gen Virol 2002 83 Pt 8 2059 2073 12124470
3. Complete genomes, phylogenetic relatedness, and structural proteins of six strains of the hepatitis B virus, four of which represent two new genotypes. H Norder AM Courouce LO Magnius, Virology 1994 198 2 489 503 10.1006/viro.1994.1060 8291231
4. A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness. L Stuyver S De Gendt C Van Geyt F Zoulim M Fried RF Schinazi R Rossau, J Gen Virol 2000 81 Pt 1 67 74 10640543
5. Hepatitis B virus taxonomy and hepatitis B virus genotypes. S Schaefer, World J Gastroenterol 2007 13 1 14 21 17206751
6. High proportion of subgroup A' (genotype A) among Brazilian isolates of Hepatitis B virus. NM Araujo FC Mello CF Yoshida C Niel SA Gomes, Arch Virol 2004 149 7 1383 1395 10.1007/s00705-003-0269-4 15221538
7. A unique segment of the hepatitis B virus group A genotype identified in isolates from South Africa. SM Bowyer L van Staden MC Kew JG Sim, J Gen Virol 1997 78 Pt 7 1719 1729 9225049
8. Identification of hepatitis B virus subgenotype A3 in rural Gabon. M Makuwa S Souquiere P Telfer C Apetrei M Vray I Bedjabaga A Mouinga-Ondeme R Onanga PA Marx M Kazanji P Roques F Simon, J Med Virol 2006 78 9 1175 1184 10.1002/jmv.20678 16847965
9. A new subtype (subgenotype) Ac (A3) of hepatitis B virus and recombination between genotypes A and E in Cameroon. F Kurbanov Y Tanaka K Fujiwara F Sugauchi D Mbanya L Zekeng N Ndembi C Ngansop L Kaptue T Miura E Ido M Hayami H Ichimura M Mizokami, J Gen Virol 2005 86 Pt 7 2047 2056 10.1099/vir.0.80922-0 15958684
10. Hepatitis B virus: significance of genotypes. S Schaefer, J Viral Hepat 2005 12 2 111 124 10.1111/j.1365-2893.2005.00584.x 15720525
11. Genotypes and S-gene variability of Mexican hepatitis B virus strains. LV Sanchez M Maldonado BE Bastidas-Ramirez H Norder A Panduro, J Med Virol 2002 68 1 24 32 10.1002/jmv.10166 12210427
12. Characteristics of hepatitis B virus isolates of genotype G and their phylogenetic differences from the other six genotypes (A through F). H Kato E Orito RG Gish F Sugauchi S Suzuki R Ueda Y Miyakawa M Mizokami, J Virol 2002 76 12 6131 6137 12021346 10.1128/JVI.76.12.6131-6137.2002
13. Difference of hepatitis B virus genotype distribution in two groups of mexican patients with different risk factors. High prevalence of genotype H and G. LV Sanchez Y Tanaka M Maldonado M Mizokami A Panduro, Intervirology 2007 50 1 9 15 10.1159/000096307 17164552
14. Hepatitis B e antigen in sera from individuals infected with hepatitis B virus of genotype G. H Kato E Orito RG Gish N Bzowej M Newsom F Sugauchi S Suzuki R Ueda Y Miyakawa M Mizokami, Hepatology 2002 35 4 922 929 10.1053/jhep.2002.32096 11915040
15. Hepatitis B virus genotype G monoinfection and its transmission by blood components. M Chudy M Schmidt V Czudai H Scheiblauer S Nick M Mosebach MK Hourfar E Seifried WK Roth E Grunelt CM Nübling, Hepatology 2006 44 1 99 107 10.1002/hep.21220 16799987
16. Hepatitis B virus genotype G is an extremely rare genotype in Japan. H Kato F Sugauchi A Ozasa T Kato Y Tanaka H Sakugawa M Sata K Hino M Onji T Okanoue E Tanaka S Kawata K Suzuki S Hige T Ohno E Orito R Ueda M Mizokami, Hepatol Res 2004 30 4 199 203 10.1016/j.hepres.2004.09.004 15589126
17. Genetic diversity of hepatitis B virus strains isolated in Rio de Janeiro, Brazil. C Niel MT Moraes AM Gaspar CF Yoshida SA Gomes, J Med Virol 1994 44 2 180 186 10.1002/jmv.1890440212 7852959
18. Sequence analysis of pre-S/S gene of hepatitis B virus strains of genotypes A, D, and F isolated in Brazil. MT Moraes SA Gomes C Niel, Arch Virol 1996 141 9 1767 1773 10.1007/BF01718299 8893798
19. Hepatitis B virus infection in isolated Afro-Brazilian communities. AR Motta-Castro RM Martins CF Yoshida SA Teles AM Paniago KM Lima SA Gomes, J Med Virol 2005 77 2 188 193 10.1002/jmv.20435 16121385
20. Effects of lamivudine on replication of hepatitis B virus in HIV-infected men. Y Benhamou C Katlama F Lunel A Coutellier E Dohin N Hamm R Tubiana S Herson T Poynard P Opolon, Ann Intern Med 1996 125 9 705 712 8929003
21. Management of YMDD mutations during lamivudine therapy in patients with chronic hepatitis B. YF Liaw, J Gastroenterol Hepatol 2002 17 Suppl 3 S333 S337 10.1046/j.1440-1746.17.s3.23.x 12472959
22. Quantitation of hepatitis B viremia and emergence of YMDD variants in patients with chronic hepatitis B treated with lamivudine. J Gauthier EJ Bourne MW Lutz LM Crowther JL Dienstag NA Brown LD Condreay, J Infect Dis 1999 180 6 1757 1762 10.1086/315147 10558928
23. Therapeutic advances in chronic hepatitis B. CL Lai, J Gastroenterol Hepatol 2004 19 Suppl S5 9 10.1111/j.1440-1746.2003.03391.x 15156927
24. The virological and clinical significance of mutations in the overlapping envelope and polymerase genes of hepatitis B virus. J Torresi, J Clin Virol 2002 25 2 97 106 10.1016/S1386-6532(02)00049-5 12367644
25. Rapid detection of lamivudine-resistant hepatitis B virus polymerase gene variants. R Jardi M Buti F Rodriguez-Frias M Cotrina X Costa C Pascual R Esteban J Guardia, J Virol Methods 1999 83 1-2 181 187 10.1016/S0166-0934(99) 00125-1 10598095
26. Clearance of the original hepatitis B virus YMDD-motif mutants with emergence of distinct lamivudine-resistant mutants during prolonged lamivudine therapy. CT Yeh RN Chien CM Chu YF Liaw, Hepatology 2000 31 6 1318 1326 10.1053/jhep.2000.7296 10827158
27. Evaluation of chronic hepatitis B virus (HBV) infection in coinfected patients receiving lamivudine as a component of anti-human immunodeficiency virus regimens. J Hoff F Bani-Sadr M Gassin F Raffi, Clin Infect Dis 2001 32 6 963 969 10.1086/319368 11247719
28. Hepatitis B virus (HBV) mutations associated with resistance to lamivudine in patients coinfected with HBV and human immunodeficiency virus. V Thibault Y Benhamou C Seguret M Bochet C Katlama F Bricaire P Opolon T Poynard H Agut, J Clin Microbiol 1999 37 9 3013 3016 10449493
29. Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy. YF Liaw RN Chien CT Yeh SL Tsai CM Chu, Hepatology 1999 30 2 567 572 10.1002/hep.510300221 10421670
30. Resistance of human hepatitis B virus to reverse transcriptase inhibitors: from genotypic to phenotypic testing. D Durantel MN Brunelle E Gros S Carrouee-Durantel C Pichoud S Villet C Trepo F Zoulim, J Clin Virol 2005 34 Suppl 1 S34 43 10.1016/S1386-6532(05)80008-3 16461221
31. Therapeutic options for chronic hepatitis B: considerations and controversies. IM Jacobson, Am J Gastroenterol 2006 101 Suppl 1 S13 18 10.1111/j.1572-0241.2006.00477.x 16448447
32. Reduced antigenicity of the hepatitis B virus HBsAg protein arising as a consequence of sequence changes in the overlapping polymerase gene that are selected by lamivudine therapy. J Torresi L Earnest-Silveira G Deliyannis K Edgtton H Zhuang SA Locarnini J Fyfe T Sozzi DC Jackson, Virology 2002 293 2 305 313 10.1006/viro.2001.1246 11886250
33. Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation. MM Bartholomew RW Jansen LJ Jeffers KR Reddy LC Johnson H Bunzendahl LD Condreay AG Tzakis ER Schiff NA Brown, Lancet 1997 349 9044 20 22 10.1016/S0140-6736(96)02266-0 8988118
34. Prevalence and characterization of lamivudine-resistant hepatitis B virus mutations in HIV-HBV co-infected individuals. L Cooley A Ayres A Bartholomeusz S Lewin S Crowe A Mijch S Locarnini J Sasadeusz, Aids 2003 17 11 1649 1657 10.1097/00002030-200307250-00009 12853747
35. Monitoring the emergence of hepatitis B virus polymerase gene variants during lamivudine therapy in human immunodeficiency virus coinfected patients: performance of CLIP sequencing and line probe assay. AM Roque-Afonso MP Ferey V Mackiewicz L Fki E Dussaix, Antivir Ther 2003 8 6 627 634 14760897
36. Patterns of hepatitis B virus infection in Brazilian human immunodeficiency virus infected patients: high prevalence of occult infection and low frequency of lamivudine resistant mutations. MV Sucupira FC Mello EA Santos C Niel VC Rolla J Arabe SA Gomes, Mem Inst Oswaldo Cruz 2006 101 6 655 660 10.1590/S0074-02762006000600013 17072479
37. Response to long-term lamivudine treatment in patients infected with hepatitis B virus genotypes A, B, and C. M Kobayashi F Suzuki N Akuta Y Suzuki Y Arase K Ikeda T Hosaka H Sezaki M Kobayashi S Iwasaki J Sato S Watahiki Y Miyakawa H Kumada, J Med Virol 2006 78 10 1276 1283 10.1002/jmv.20701 16927289
38. A case-control study of response to lamivudine therapy for 2 years in Japanese and Chinese patients chronically infected with hepatitis B virus of genotypes Bj, Ba and C. E Orito K Fujiwara Y Tanaka MF Yuen CL Lai T Kato F Sugauchi A Kusakabe M Sata T Okanoue H Niitsuma H Sakugawa I Hasegawa M Mizokami, Hepatol Res 2006 35 2 127 134 10.1016/j.hepres.2006.03.005 16621686
39. Early dynamics of hepatitis B virus in chimeric mice carrying human hepatocytes monoinfected or coinfected with genotype G. M Sugiyama Y Tanaka T Sakamoto I Maruyama T Shimada S Takahashi T Shirai H Kato M Nagao Y Miyakawa M Mizokami, Hepatology 2007 45 4 929 937 10.1002/hep.21584 17393501
40. Evaluation of the INNO-LiPA HBV genotyping assay for determination of hepatitis B virus genotype. C Osiowy E Giles, J Clin Microbiol 2003 41 12 5473 5477 14662927 10.1128/JCM.41.12.5473-5477.2003
41. Detection of HBV DNA using real time analysis. SD Pas HG Niesters, J Clin Virol 2002 25 1 93 94 10.1016/S1386-6532(02)00016-1 12126725
42. MEGA3: Integrated software for Molecular Evolutionary Genetics Analysis and sequence alignment. S Kumar K Tamura M Nei, Brief Bioinform 2004 5 2 150 163 10.1093/bib/5.2.150 15260895
43. Hepatitis B virus genetic variability and evolution. A Kay F Zoulim, Virus Res 2007 127 2 164 176 10.1016/j.virusres.2007.02.021 17383765